CK BIOTECH has a total of 12 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are APPLIED PHARMA RES, ZD EHKOLOGICHESKOJ TEKHN I EHK and KANGMEI BEIJING PHARMACEUTICAL RES INSTITUTE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Specific use of cosmetics | |
#5 | Special foods | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Choi Kang-Yell | 7 |
#2 | Park Jiyeon | 5 |
#3 | Shim Jiyong | 4 |
#4 | Ryu Yeong Chan | 4 |
#5 | Kang Yell Choi | 3 |
#6 | Seol Hwa Seo | 2 |
#7 | Han Gyoon Hee | 2 |
#8 | Kim Eunhwan | 2 |
#9 | Seo Seol Hwa | 2 |
#10 | Choi Kang Yell | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020009503A1 | Pharmaceutical composition comprising indirubin derivative as active ingredient | |
KR20210005355A | composition for preventing or treating for preventing or treating diabetic wound comprising Indirubin derivative compound | |
WO2019027239A2 | Composition for preventing hair loss or promoting hair growth | |
KR20190013575A | composition for preventing of hair loss or promoting hair growth | |
KR20200005188A | composition for preventing or treating of wound comprising Indirubin derivative compound | |
KR20180119941A | A pharmaceutical composition for wound healing comprising extract of Euodia sutchuenensis Dode | |
KR101855423B1 | A composition comprising 5,6-dichloroindirubin-3'-methoxime and 5-methoxylindirubin-3'-oxime |